By Jenny Shmuel and Tucker Terhufen ( March 10, 2020, 4:10 PM EDT) -- On March 5, the U.S. Court of Appeals for the Federal Circuit issued a Rule 36 affirmance in Janssen Biotech Inc. v. Celltrion Healthcare Co. Ltd., resolving in Celltrion's favor a long-standing dispute over its biosimilar of Janssen's Remicade (infliximab)....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.